[Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma]

Vojnosanit Pregl. 2008 Mar;65(3):229-33. doi: 10.2298/vsp0803229m.

[Article in Serbian]

Authors

Biljana Mihaljević¹, Snezana Janković, Ljubomir Jaković, Maja Perunicić Jovanović, Bosko Andelić, Violeta Milosević, Aleksandra Sretenović, Marjana Virijević, Milan Petrovic

Affiliation

¹ Klinicki Centar Srbije, Institut za Hematologiju, Beograd.

PMID: 18494271
DOI: 10.2298/vsp0803229m

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20*
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Rituximab

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Rituximab